In a small clinical pilot study, probable AD patients given alpha-lipoic acid and two choline acetyltransferase (CAT) inhibitors had slower cognitive decline than probable AD patients given only the two CAT inhibitors [151]. Here, CHAT is linked to Alzheimer disease.